Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy
Article in Frontiers in Pharmacology (June 2024)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (June 2024)
Article in ACS Applied Bio Materials (May 2024)
Article in Biomedicines (April 2024)